companies that make glp 1 drugs Study predicts 16 new obesity may come to market Asia-Pacific Glucagon-like Peptide-1 (GLP-1) Agonists
Description
- Represented by Motley Rice
Synthetic exendin-4 was named exenatide and, without further modification, was the first GLP-1 receptor agonist approved to treat type 2 diabetes
Peptide therapeutics: current status and future directions
Ma D, Liu X, Liu J, et al
[DOI] [PubMed] [Google Scholar] 57.Deol H, Lekkakou L, Viswanath AK, Pappachan JM
And theres hope that as more pharmaceutical companies develop their own versions of these drugs, competition will drive prices down
